Antilymphocyte Serum

This is a type of medicine made from animal blood. It contains antibodies that target lymphocytes, which are a type of white blood cell. Doctors use it to help prevent rejection after organ transplants, especially heart or lung transplants. It's also used in tests to check for compatibility before transplants.

Brand names:ATGAM, Thymoglobulin
Medication

What people taking Antilymphocyte Serum report

Every report comes from a Lived member, sent anonymously.

Have you tried Antilymphocyte Serum for Aplastic Anemia?

NameHow it went

About Antilymphocyte Serum

What It's For

Antilymphocyte serum is an older name for anti-thymocyte globulin, often shortened to ATG. It is a purified concentrate of antibodies, made in animals, that targets the body's own immune cells and is used to suppress the immune system strongly for a short period. Two products are sold in the US: ATGAM, which is made in horses (equine ATG), and Thymoglobulin, which is made in rabbits (rabbit ATG). Both are used in kidney transplantation. Thymoglobulin is approved for adults and children to help prevent rejection around the time of a kidney transplant and to treat an episode of acute rejection. ATGAM is approved to treat rejection of a transplanted kidney, given alongside the person's usual anti-rejection medicines. Outside its US approval, rabbit ATG is also used before some donor stem cell transplants, where studies show it lowers the risk of graft-versus-host disease (donor immune cells attacking the recipient's body), though it has not clearly improved overall survival. ATGAM is also approved for moderate to severe aplastic anemia, a condition in which the immune system damages the bone marrow so it stops making enough blood cells, in people who are not suitable for a bone marrow transplant. For this use it is combined with cyclosporine, another immune-suppressing medicine, and often with eltrombopag, a pill that stimulates blood cell production. In a head-to-head trial, horse ATG worked clearly better than rabbit ATG as a first treatment for severe aplastic anemia. Despite the word serum, ATG does not protect against infection. It does the opposite, weakening part of the immune system on purpose.

How It Works

Lymphocytes are white blood cells that direct immune attacks, and T cells are the type mainly responsible for rejecting a transplanted organ. ATG is made by exposing horses or rabbits to human thymus cells (the thymus is where T cells mature) and then purifying the antibodies the animals produce. Once infused, these antibodies attach to many proteins on the surface of human lymphocytes. The main result is a rapid fall in circulating T cells, usually within a day of the first dose, along with changes that blunt how the remaining T cells activate and attack. Researchers do not fully understand every step of how ATG works. In a transplant, this pause in T-cell activity helps protect the new kidney while other anti-rejection medicines take hold, or calms an active rejection episode. Thymoglobulin has not been shown to work against antibody-mediated rejection, a different type driven by antibodies rather than T cells. In aplastic anemia, the aim is to switch off the immune attack on the bone marrow so it can recover and resume making blood cells.

Dosage & Administration

ATG is given only in a hospital or specialized infusion setting, as a slow infusion into a vein, by teams experienced in transplant or blood disorder care. ATGAM is usually given through a large central vein, a dialysis fistula or a shunt, because smaller veins can become inflamed or clot. Each dose runs for several hours: at least 6 hours for the first Thymoglobulin dose, and at least 4 hours for later doses and for ATGAM. About an hour beforehand, people usually receive a steroid, acetaminophen and an antihistamine to lessen fever, chills and other infusion reactions. Before ATGAM, an allergist may do skin testing for sensitivity to horse proteins, although a negative test does not rule out a reaction. The dose is based on body weight and given once a day for a set course. Thymoglobulin typically runs 4 to 7 days to prevent rejection and 7 to 14 days to treat it. ATGAM usually runs 8 to 14 days for aplastic anemia and 14 days for kidney rejection, sometimes followed by extra doses on alternate days. The horse and rabbit products contain different antibodies in different amounts, so their doses are very different and one cannot be swapped for the other. Blood counts are checked during and after treatment, because ATG can lower white blood cells and platelets (the cells that help blood clot). The team may lower the dose or stop early if counts fall too far.

Side Effects

Fever, chills and rash are the most common reactions, especially with the first infusion, and are the reason for premedication and slow infusion rates. Headache, nausea, joint or muscle aches, changes in blood pressure, and itching or hives can also occur. Lower white cell and platelet counts are common and are usually found on blood tests rather than felt, although low platelets can show up as easier bruising or bleeding. The most serious immediate risks are anaphylaxis, a severe allergic reaction to the animal proteins, and cytokine release syndrome, a surge of inflammatory signals as lymphocytes are destroyed, which can cause high fever, low blood pressure, chest pain and breathing trouble. Both can be life-threatening. That is why infusions happen where staff can treat them at once, and why people receiving ATGAM are monitored during the infusion and for at least 24 hours afterward. Trouble breathing, throat or chest tightness, widespread hives or feeling faint during or after an infusion should be reported to the nurse right away. Serum sickness is a delayed immune reaction to the animal protein, appearing later than infusion reactions, with rash, joint pain, fever and chills. It is uncommon, but these symptoms are worth reporting to the care team.

Interactions & Warnings

ATG is not given to someone who has had a severe allergic reaction to the same kind of animal protein before: horse proteins for ATGAM, rabbit proteins for Thymoglobulin. Thymoglobulin is also not used during an active infection that makes further immune suppression unsafe. Because ATG suppresses the immune system so strongly, serious infections can follow. These include bacterial, fungal and viral infections, and the reawakening of viruses already in the body, such as cytomegalovirus (CMV), a common virus that can cause fever, pneumonia or other organ problems in people with weakened immunity. Teams commonly prescribe preventive antiviral medicine, and sometimes antibacterial or antifungal medicine, around treatment. Over the longer term, strong immune suppression raises the risk of some cancers, particularly lymphoma. ATG is used together with steroids and other anti-rejection or immune-suppressing medicines, and the team balances their combined effect; lowering those other medicines can sometimes unmask a reaction to ATG. Live vaccines, such as the measles, mumps and rubella (MMR) vaccine or the chickenpox vaccine, should not be given shortly before, during or after ATG treatment, so it is worth confirming timing with the team before any vaccination. ATG can interfere with some antibody-based lab tests, including the crossmatch tests used to match transplant donors. Because ATGAM is made from horse and human blood components, it carries a small theoretical risk of transmitting infections. Its safety in pregnancy is not established, and it is used then only when the benefit is judged to outweigh the risk.

What to Expect

Treatment usually happens during a hospital stay, either around the transplant operation or during an admission for rejection or aplastic anemia. The first infusion tends to bring the most fever and chills, and later doses are often easier. Frequent blood tests track white cells and platelets, and platelet transfusions may be needed, especially in aplastic anemia. After a kidney transplant, success means a working kidney without rejection, followed through kidney function blood tests over the following weeks and months. In aplastic anemia, recovery is slower: blood counts improve gradually, and doctors typically judge the response several months later (the main comparison trial measured it at 6 months). Not everyone responds, and people who do not may be considered for other options, including a stem cell transplant. The immune system stays suppressed for a while after the course ends, so fever, chills or other signs of infection afterward should be reported to the transplant or hematology team promptly rather than waited out.

Questions to Ask Your Doctor

  1. 1.Why is ATG recommended for me, and will I receive the horse or the rabbit product?
  2. 2.What will the infusions be like, and how will reactions such as fever or breathing trouble be handled?
  3. 3.Which preventive medicines will I take against infections, and for how long?
  4. 4.Which vaccines should I get or avoid before and after treatment?
  5. 5.How will we know whether the treatment worked, and what happens if it does not?

Last reviewed • Oct 2026

Educational content, not medical advice.